115 related articles for article (PubMed ID: 34807805)
1. Impact of comorbidity on renal cell carcinoma prognosis: a nationwide cohort study.
Horsbøl TA; Dalton SO; Christensen J; Petersen AC; Azawi N; Donskov F; Holm ML; Nørgaard M; Lund L
Acta Oncol; 2022 Jan; 61(1):58-63. PubMed ID: 34807805
[TBL] [Abstract][Full Text] [Related]
2. The prognostic impact of comorbidities on renal cancer, 1995 to 2006: a Danish population based study.
Lund L; Jacobsen J; Nørgaard M; McLaughlin JK; Blot WJ; Borre M; Sørensen HT
J Urol; 2009 Jul; 182(1):35-40; discussion 40. PubMed ID: 19450859
[TBL] [Abstract][Full Text] [Related]
3. Effect of comorbidity on risk of venous thromboembolism in patients with renal cell carcinoma.
Smith AB; Horvath-Puhó E; Nielsen ME; Lash TL; Baron JA; Sørensen HT
Urol Oncol; 2014 May; 32(4):466-72. PubMed ID: 24767684
[TBL] [Abstract][Full Text] [Related]
4. Survival benefits analyses of T1a renal cell carcinoma patients treated with microwave ablation.
Hou Q; Yu X; Cheng Z; Han Z; Liu F; Dou J; Yu J; Liang P
Eur J Radiol; 2021 Nov; 144():109951. PubMed ID: 34607288
[TBL] [Abstract][Full Text] [Related]
5. Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990-2008.
Land LH; Dalton SO; Jensen MB; Ewertz M
Breast Cancer Res Treat; 2012 Feb; 131(3):1013-20. PubMed ID: 22002567
[TBL] [Abstract][Full Text] [Related]
6. Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors.
Schwartz K; Ruterbusch JJ; Colt JS; Miller DC; Chow WH; Purdue MP
Cancer Med; 2016 Feb; 5(2):200-8. PubMed ID: 26710924
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index.
Santos Arrontes D; Fernández Aceñero MJ; García González JI; Martín Muñoz M; Paniagua Andrés P
J Urol; 2008 Mar; 179(3):857-61. PubMed ID: 18221956
[TBL] [Abstract][Full Text] [Related]
8. Progression in comorbidity before hemodialysis initiation is a valuable predictor of survival in incident patients.
Ng YY; Hung YN; Wu SC; Ko PJ; Hwang SM
Nephrol Dial Transplant; 2013 Apr; 28(4):1005-12. PubMed ID: 23197681
[TBL] [Abstract][Full Text] [Related]
9. Validity of the age-adjusted charlson comorbidity index on clinical outcomes for patients with nasopharyngeal cancer post radiation treatment: a 5-year nationwide cohort study.
Yang CC; Chen PC; Hsu CW; Chang SL; Lee CC
PLoS One; 2015; 10(1):e0117323. PubMed ID: 25617629
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of renal cell carcinoma in patients less than 40 years of age and older age patients: A retrospective single-center study.
Pal DK; Maurya AK; Jana D
Indian J Cancer; 2018; 55(3):297-300. PubMed ID: 30693898
[TBL] [Abstract][Full Text] [Related]
11. Predicting mortality of incident dialysis patients in Taiwan--a longitudinal population-based study.
Wu PH; Lin YT; Lee TC; Lin MY; Kuo MC; Chiu YW; Hwang SJ; Chen HC
PLoS One; 2013; 8(4):e61930. PubMed ID: 23626754
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors of renal cell cancer in elderly patients: a population-based cohort study.
Pajunen H; Veitonmäki T; Huhtala H; Nikkola J; Pöyhönen A; Murtola T
Sci Rep; 2024 Mar; 14(1):6295. PubMed ID: 38491173
[TBL] [Abstract][Full Text] [Related]
13. Association of Short-Term Mortality of Venous Thromboembolism with Family History of Venous Thromboembolism and Charlson Comorbidity Index.
Zöller B; Pirouzifard M; Sundquist J; Sundquist K
Thromb Haemost; 2019 Jan; 119(1):48-55. PubMed ID: 30597499
[TBL] [Abstract][Full Text] [Related]
14. The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database.
Bøje CR; Dalton SO; Grønborg TK; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
Acta Oncol; 2013 Feb; 52(2):285-93. PubMed ID: 23320773
[TBL] [Abstract][Full Text] [Related]
15. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database.
Bøje CR; Dalton SO; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
Radiother Oncol; 2014 Jan; 110(1):91-7. PubMed ID: 24412015
[TBL] [Abstract][Full Text] [Related]
17. Comorbidity Assessment Using Charlson Comorbidity Index and Simplified Comorbidity Score and Its Association With Clinical Outcomes During First-Line Chemotherapy for Lung Cancer.
Singh N; Singh PS; Aggarwal AN; Behera D
Clin Lung Cancer; 2016 May; 17(3):205-213.e1. PubMed ID: 26589440
[TBL] [Abstract][Full Text] [Related]
18. Early life body size in relation to risk of renal cell carcinoma in adulthood: a Danish observational cohort study.
Jensen BW; Meyle KD; Madsen K; Sørensen TIA; Baker JL
Eur J Epidemiol; 2020 Mar; 35(3):251-258. PubMed ID: 31993884
[TBL] [Abstract][Full Text] [Related]
19. [Risk factors associated with mortality in patient with non-high-risk pulmonary embolism and cancer and the prognostic value of Charlson comorbidity index].
Zhou C; Wang YX; Zhong X; Yang ZH; Zhang M; Zhou HX; Yi Q
Zhonghua Yi Xue Za Zhi; 2020 Aug; 100(30):2383-2387. PubMed ID: 32791816
[No Abstract] [Full Text] [Related]
20. A nationwide study of comorbidity and risk of reinfection after Staphylococcus aureus bacteraemia.
Wiese L; Mejer N; Schønheyder HC; Westh H; Jensen AG; Larsen AR; Skov R; Benfield T;
J Infect; 2013 Sep; 67(3):199-205. PubMed ID: 23664855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
